FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Clin Vaccine Immunol / Monoclonal antibody-based competitive enzyme-linked immunoso...
Clinical and vaccine immunology : CVI2006; 14(2); 134-138; doi: 10.1128/CVI.00322-06

Monoclonal antibody-based competitive enzyme-linked immunosorbent assay for detecting and quantifying West Nile virus-neutralizing antibodies in horse sera.

Abstract: A rapid immunoassay for detecting and quantifying West Nile virus (WNV)-neutralizing antibodies in sera was developed as an alternative to the plaque reduction neutralization test (PRNT), the gold standard test for WNV. The assay is a competitive, enzyme-linked immunosorbent assay using neutralizing monoclonal antibody 5E8 (NT-ELISA). A cutoff percent inhibition (PI) value of 35% (mean PI plus 3 standard deviations), with a specificity of 99%, was established based on analysis of 246 serum samples from horses free of WNV. The NT-ELISA detected neutralizing antibodies in all sera collected 7 or 14 days postinoculation from mice (n = 11) infected with lineage I (strain NY385-99) or II (strain B956) WNV. When sera from WNV-vaccinated horses (n = 212) were tested by NT-ELISA and PRNT, the NT-ELISA gave a positive result for 96.1% (173/180) of the PRNT-positive sera and 3.1% (1/32) of the PRNT-negative sera. Discrepancies between the two tests were observed mainly with sera with low PRNT(90) titers (expressed as the reciprocal of the highest dilution yielding > or = 90% reduction in the number of plaques) for WNV or low PIs by NT-ELISA. The overall agreement (k value) between the two tests was 0.86. A good correlation (r(2) = 0.77) was also observed between the tests for endpoint titration of sera (n = 116). In conclusion, the newly developed NT-ELISA may be a good alternative serologic assay for detecting WNV that can be used for large-scale testing of WNV-neutralizing antibodies in multiple species.
Get Full Text
Publication Date: 2006-11-29 PubMed ID: 17135450PubMed Central: PMC1797797DOI: 10.1128/CVI.00322-06Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research is about a new immunoassay for detecting and quantifying West Nile virus (WNV) antibodies in horses serum. The assay, known as NT-ELISA, provides a quicker and more effective alternative to the plaque reduction neutralization test (PRNT) which is currently the gold standard for testing WNV.

Objective and Method

  • The research aimed to create a fast and efficient process, NT-ELISA, for detecting WNV antibodies in serum especially from horses. It was meant to offer a more effective alternative to PRNT.
  • The research involved developing a competitive enzyme-linked immunosorbent assay using the monoclonal antibody 5E8 for neutralizing WNV.

Test Validation

  • For validating this new assay, a cutoff percent inhibition value of 35% was set with a specificity of 99%, derived from the analysis of 246 horse serum samples free of WNV.
  • The NT-ELISA was tested on the sera taken from mice seven or 14 days after being inoculated with either lineage I or II WNV. It was able to detect neutralizing antibodies in all tested sera.

Comparison with PRNT

  • The researchers tested 212 horse serum samples vaccinated for WNV using both NT-ELISA and PRNT. NT-ELISA showed a positive result for 96.1% of PRNT positive sera and 3.1% of PRNT negative sera.
  • There were some discrepancies noticed between the results of two tests, especially with the sera which demonstrated low PRNT(90) titers or low PIs using NT-ELISA.
  • The overall agreement rate, denoted by k value, was relatively high at 0.86 indicating good agreement between the NT-ELISA and PRNT results.

Conclusion

  • The research concluded that NT-ELISA can be a reliable alternative for detecting and quantitating WNV-neutralizing antibodies. This assay could be particularly useful for large-scale testing involving multiple species.

Cite This Article

APA
Choi KS, Ko YJ, Nah JJ, Kim YJ, Kang SY, Yoon KJ, Joo YS. (2006). Monoclonal antibody-based competitive enzyme-linked immunosorbent assay for detecting and quantifying West Nile virus-neutralizing antibodies in horse sera. Clin Vaccine Immunol, 14(2), 134-138. https://doi.org/10.1128/CVI.00322-06

Publication

Clinical and vaccine immunology : CVI
ISSN: 1556-6811
NlmUniqueID: 101252125
Country: United States
Language: English
Volume: 14
Issue: 2
Pages: 134-138

Researcher Affiliations

Choi, Kang-Seuk
  • National Veterinary Research and Quarantine Service, 480 Anyang-6 dong, Anyang, Gyeonggi 430-824, Republic of Korea. choiks@nvrqs.go.kr
Ko, Young-Joon
    Nah, Jin-Ju
      Kim, Yong-Joo
        Kang, Shien-Young
          Yoon, Kyoung-Jin
            Joo, Yi-Seok

              MeSH Terms

              • Animals
              • Antibodies / blood
              • Antibodies, Monoclonal
              • Enzyme-Linked Immunosorbent Assay
              • Horses / blood
              • Horses / immunology
              • Serum / immunology
              • West Nile virus / immunology

              References

              This article includes 37 references
              1. Arroyo J, Miller C, Catalan J, Myers GA, Ratterree MS, Trent DW, Monath TP. ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy.. J Virol 2004 Nov;78(22):12497-507.
                pmc: PMC525070pubmed: 15507637doi: 10.1128/jvi.78.22.12497-12507.2004google scholar: lookup
              2. Beasley DW, Barrett AD. Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein.. J Virol 2002 Dec;76(24):13097-100.
                pmc: PMC136710pubmed: 12438639doi: 10.1128/jvi.76.24.13097-13100.2002google scholar: lookup
              3. Beasley DW, Holbrook MR, Travassos Da Rosa AP, Coffey L, Carrara AS, Phillippi-Falkenstein K, Bohm RP Jr, Ratterree MS, Lillibridge KM, Ludwig GV, Estrada-Franco J, Weaver SC, Tesh RB, Shope RE, Barrett AD. Use of a recombinant envelope protein subunit antigen for specific serological diagnosis of West Nile virus infection.. J Clin Microbiol 2004 Jun;42(6):2759-65.
                pmc: PMC427824pubmed: 15184463doi: 10.1128/jcm.42.6.2759-2765.2004google scholar: lookup
              4. Bin H, Grossman Z, Pokamunski S, Malkinson M, Weiss L, Duvdevani P, Banet C, Weisman Y, Annis E, Gandaku D, Yahalom V, Hindyieh M, Shulman L, Mendelson E. West Nile fever in Israel 1999-2000: from geese to humans.. Ann N Y Acad Sci 2001 Dec;951:127-42.
                pubmed: 11797770doi: 10.1111/j.1749-6632.2001.tb02691.xgoogle scholar: lookup
              5. Blitvich BJ, Marlenee NL, Hall RA, Calisher CH, Bowen RA, Roehrig JT, Komar N, Langevin SA, Beaty BJ. Epitope-blocking enzyme-linked immunosorbent assays for the detection of serum antibodies to west nile virus in multiple avian species.. J Clin Microbiol 2003 Mar;41(3):1041-7.
                pmc: PMC150274pubmed: 12624027doi: 10.1128/jcm.41.3.1041-1047.2003google scholar: lookup
              6. Choi KS, Nah JJ, Ko YJ, Kim YJ, Joo YS. The DE loop of the domain III of the envelope protein appears to be associated with West Nile virus neutralization.. Virus Res 2007 Feb;123(2):216-8.
                doi: 10.1016/j.viruses.2006.09.002pubmed: 17027114google scholar: lookup
              7. Chu JJH, Rajamanonmani R, Li J, Bhuvanakantham R, Lescar J, Ng ML. Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein.. J Gen Virol 2005 Feb;86(Pt 2):405-412.
                pubmed: 15659760doi: 10.1099/vir.0.80411-0google scholar: lookup
              8. Dauphin G, Zientara S, Zeller H, Murgue B. West Nile: worldwide current situation in animals and humans.. Comp Immunol Microbiol Infect Dis 2004 Sep;27(5):343-55.
                pubmed: 15225984doi: 10.1016/j.cimid.2004.03.009google scholar: lookup
              9. Davis BS, Chang GJ, Cropp B, Roehrig JT, Martin DA, Mitchell CJ, Bowen R, Bunning ML. West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays.. J Virol 2001 May;75(9):4040-7.
                pmc: PMC114149pubmed: 11287553doi: 10.1128/jvi.75.9.4040-4047.2001google scholar: lookup
              10. Desprès P, Combredet C, Frenkiel MP, Lorin C, Brahic M, Tangy F. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis.. J Infect Dis 2005 Jan 15;191(2):207-14.
                pubmed: 15609230doi: 10.1086/426824google scholar: lookup
              11. Granwehr BP, Lillibridge KM, Higgs S, Mason PW, Aronson JF, Campbell GA, Barrett AD. West Nile virus: where are we now?. Lancet Infect Dis 2004 Sep;4(9):547-56.
                pubmed: 15336221doi: 10.1016/s1473-3099(04)01128-4google scholar: lookup
              12. Hall RA, Nisbet DJ, Pham KB, Pyke AT, Smith GA, Khromykh AA. DNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virus.. Proc Natl Acad Sci U S A 2003 Sep 2;100(18):10460-4.
                pmc: PMC193583pubmed: 12917491doi: 10.1073/pnas.1834270100google scholar: lookup
              13. Hogrefe WR, Moore R, Lape-Nixon M, Wagner M, Prince HE. Performance of immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays using a West Nile virus recombinant antigen (preM/E) for detection of West Nile virus- and other flavivirus-specific antibodies.. J Clin Microbiol 2004 Oct;42(10):4641-8.
                pmc: PMC522294pubmed: 15472323doi: 10.1128/jcm.42.10.4641-4648.2004google scholar: lookup
              14. Holmes DA, Purdy DE, Chao DY, Noga AJ, Chang GJ. Comparative analysis of immunoglobulin M (IgM) capture enzyme-linked immunosorbent assay using virus-like particles or virus-infected mouse brain antigens to detect IgM antibody in sera from patients with evident flaviviral infections.. J Clin Microbiol 2005 Jul;43(7):3227-36.
                pmc: PMC1169144pubmed: 16000440doi: 10.1128/jcm.43.7.3227-3236.2005google scholar: lookup
              15. Huang CY, Silengo SJ, Whiteman MC, Kinney RM. Chimeric dengue 2 PDK-53/West Nile NY99 viruses retain the phenotypic attenuation markers of the candidate PDK-53 vaccine virus and protect mice against lethal challenge with West Nile virus.. J Virol 2005 Jun;79(12):7300-10.
                pmc: PMC1143654pubmed: 15919884doi: 10.1128/jvi.79.12.7300-7310.2005google scholar: lookup
              16. Lanciotti RS, Roehrig JT, Deubel V, Smith J, Parker M, Steele K, Crise B, Volpe KE, Crabtree MB, Scherret JH, Hall RA, MacKenzie JS, Cropp CB, Panigrahy B, Ostlund E, Schmitt B, Malkinson M, Banet C, Weissman J, Komar N, Savage HM, Stone W, McNamara T, Gubler DJ. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States.. Science 1999 Dec 17;286(5448):2333-7.
                pubmed: 10600742doi: 10.1126/science.286.5448.2333google scholar: lookup
              17. Malkinson M, Banet C. The role of birds in the ecology of West Nile virus in Europe and Africa.. Curr Top Microbiol Immunol 2002;267:309-22.
                pubmed: 12082995doi: 10.1007/978-3-642-59403-8_15google scholar: lookup
              18. Malkinson M, Banet C, Khinich Y, Samina I, Pokamunski S, Weisman Y. Use of live and inactivated vaccines in the control of West Nile fever in domestic geese.. Ann N Y Acad Sci 2001 Dec;951:255-61.
                pubmed: 11797782doi: 10.1111/j.1749-6632.2001.tb02701.xgoogle scholar: lookup
              19. Martin SW, Meek AH, Willegerg P. Veterinary epidemiology: principles and methods. p. 48-76.
              20. Minke JM, Siger L, Karaca K, Austgen L, Gordy P, Bowen R, Renshaw RW, Loosmore S, Audonnet JC, Nordgren B. Recombinant canarypoxvirus vaccine carrying the prM/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge.. Arch Virol Suppl 2004;(18):221-30.
                pubmed: 15119777doi: 10.1007/978-3-7091-0572-6_20google scholar: lookup
              21. Muerhoff AS, Dawson GJ, Dille B, Gutierrez R, Leary TP, Gupta MC, Kyrk CR, Kapoor H, Clark P, Schochetman G, Desai SM. Enzyme-linked immunosorbent assays using recombinant envelope protein expressed in COS-1 and Drosophila S2 cells for detection of West Nile virus immunoglobulin M in serum or cerebrospinal fluid.. Clin Diagn Lab Immunol 2004 Jul;11(4):651-7.
                pmc: PMC440607pubmed: 15242936doi: 10.1128/cdli.11.4.651-657.2004google scholar: lookup
              22. Ng T, Hathaway D, Jennings N, Champ D, Chiang YW, Chu HJ. Equine vaccine for West Nile virus.. Dev Biol (Basel) 2003;114:221-7.
                pubmed: 14677692
              23. Office International des Epizooties. Manual of standards for diagnostic tests and vaccines. 6th ed., p. 1064-1071.
              24. Oliphant T, Engle M, Nybakken GE, Doane C, Johnson S, Huang L, Gorlatov S, Mehlhop E, Marri A, Chung KM, Ebel GD, Kramer LD, Fremont DH, Diamond MS. Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus.. Nat Med 2005 May;11(5):522-30.
                pmc: PMC1458527pubmed: 15852016doi: 10.1038/nm1240google scholar: lookup
              25. Pierson TC, Sánchez MD, Puffer BA, Ahmed AA, Geiss BJ, Valentine LE, Altamura LA, Diamond MS, Doms RW. A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection.. Virology 2006 Mar 1;346(1):53-65.
                pubmed: 16325883doi: 10.1016/j.virol.2005.10.030google scholar: lookup
              26. Platonov AE, Shipulin GA, Shipulina OY, Tyutyunnik EN, Frolochkina TI, Lanciotti RS, Yazyshina S, Platonova OV, Obukhov IL, Zhukov AN, Vengerov YY, Pokrovskii VI. Outbreak of West Nile virus infection, Volgograd Region, Russia, 1999.. Emerg Infect Dis 2001 Jan-Feb;7(1):128-32.
                pmc: PMC2631674pubmed: 11266303doi: 10.3201/eid0701.010118google scholar: lookup
              27. Pletnev AG, Claire MS, Elkins R, Speicher J, Murphy BR, Chanock RM. Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus.. Virology 2003 Sep 15;314(1):190-5.
                pubmed: 14517072doi: 10.1016/s0042-6822(03)00450-1google scholar: lookup
              28. Qiao M, Ashok M, Bernard KA, Palacios G, Zhou ZH, Lipkin WI, Liang TJ. Induction of sterilizing immunity against West Nile Virus (WNV), by immunization with WNV-like particles produced in insect cells.. J Infect Dis 2004 Dec 15;190(12):2104-8.
                pubmed: 15551208doi: 10.1086/425933google scholar: lookup
              29. Sánchez MD, Pierson TC, McAllister D, Hanna SL, Puffer BA, Valentine LE, Murtadha MM, Hoxie JA, Doms RW. Characterization of neutralizing antibodies to West Nile virus.. Virology 2005 May 25;336(1):70-82.
                pubmed: 15866072doi: 10.1016/j.virol.2005.02.020google scholar: lookup
              30. Smithburn KC, Hughes TP, Burke AV, Paul JH. A neurotropic virus isolated from the blood of a native of Uganda. Am. J. Trop. Med. Hyg. 20:471-492.
              31. Steele KE, Linn MJ, Schoepp RJ, Komar N, Geisbert TW, Manduca RM, Calle PP, Raphael BL, Clippinger TL, Larsen T, Smith J, Lanciotti RS, Panella NA, McNamara TS. Pathology of fatal West Nile virus infections in native and exotic birds during the 1999 outbreak in New York City, New York.. Vet Pathol 2000 May;37(3):208-24.
                pubmed: 10810985doi: 10.1354/vp.37-3-208google scholar: lookup
              32. Tsai TF, Popovici F, Cernescu C, Campbell GL, Nedelcu NI. West Nile encephalitis epidemic in southeastern Romania.. Lancet 1998 Sep 5;352(9130):767-71.
                pubmed: 9737281doi: 10.1016/s0140-6736(98)03538-7google scholar: lookup
              33. Turell MJ, Bunning M, Ludwig GV, Ortman B, Chang J, Speaker T, Spielman A, McLean R, Komar N, Gates R, McNamara T, Creekmore T, Farley L, Mitchell CJ. DNA vaccine for West Nile virus infection in fish crows (Corvus ossifragus).. Emerg Infect Dis 2003 Sep;9(9):1077-81.
                pmc: PMC3016768pubmed: 14519243doi: 10.3201/eid0909.030025google scholar: lookup
              34. Wang T, Anderson JF, Magnarelli LA, Wong SJ, Koski RA, Fikrig E. Immunization of mice against West Nile virus with recombinant envelope protein.. J Immunol 2001 Nov 1;167(9):5273-7.
                pubmed: 11673542doi: 10.4049/jimmunol.167.9.5273google scholar: lookup
              35. Wang T, Magnarelli LA, Anderson JF, Gould LH, Bushmich SL, Wong SJ, Fikrig E. A recombinant envelope protein-based enzyme-linked immunosorbent assay for West Nile virus serodiagnosis.. Vector Borne Zoonotic Dis 2002 Summer;2(2):105-9.
                pubmed: 12653304doi: 10.1089/153036602321131904google scholar: lookup
              36. Weaver SC, Barrett AD. Transmission cycles, host range, evolution and emergence of arboviral disease.. Nat Rev Microbiol 2004 Oct;2(10):789-801.
                pmc: PMC7097645pubmed: 15378043doi: 10.1038/nrmicro1006google scholar: lookup
              37. Yamshchikov G, Borisevich V, Seregin A, Chaporgina E, Mishina M, Mishin V, Kwok CW, Yamshchikov V. An attenuated West Nile prototype virus is highly immunogenic and protects against the deadly NY99 strain: a candidate for live WN vaccine development.. Virology 2004 Dec 5;330(1):304-12.
                pubmed: 15527855doi: 10.1016/j.virol.2004.09.014google scholar: lookup

              Citations

              This article has been cited 7 times.
              1. Adungo F, Yu F, Kamau D, Inoue S, Hayasaka D, Posadas-Herrera G, Sang R, Mwau M, Morita K. Development and Characterization of Monoclonal Antibodies to Yellow Fever Virus and Application in Antigen Detection and IgM Capture Enzyme-Linked Immunosorbent Assay. Clin Vaccine Immunol 2016 Aug;23(8):689-97.
                doi: 10.1128/CVI.00209-16pubmed: 27307452google scholar: lookup
              2. Li J, Wei QK, Hu SL, Xiao T, Xu C, Liu X, Huang BC, Jia FJ. Establishment of lymphatic filarial specific IgG4 indirect ELISA detection method. Int J Clin Exp Med 2015;8(9):16496-503.
                pubmed: 26629176
              3. Yeh JY, Chung KM, Song J. Differentiation of West Nile virus-infected animals from vaccinated animals by competitive ELISA using monoclonal antibodies against non-structural protein 1. Vector Borne Zoonotic Dis 2012 May;12(5):380-7.
                doi: 10.1089/vbz.2011.0796pubmed: 22217168google scholar: lookup
              4. Yeh JY, Lee JH, Park JY, Seo HJ, Moon JS, Cho IS, Kim HP, Yang YJ, Ahn KM, Kyung SG, Choi IS, Lee JB. A diagnostic algorithm to serologically differentiate West Nile virus from Japanese encephalitis virus infections and its validation in field surveillance of poultry and horses. Vector Borne Zoonotic Dis 2012 May;12(5):372-9.
                doi: 10.1089/vbz.2011.0709pubmed: 22217162google scholar: lookup
              5. Zaidi SYR, Ahmed A, Sanghvi G, Roopashree R, Kashyap A, Mohammed NK, Niaz B, Saeed F, Jamil F, Akhter MN, Afzaal M, Ndagire CT. Exploring the In Vitro Anti-Inflammatory Effect of Citrus Fruit Hesperidin Supplementation. Food Sci Nutr 2025 Sep;13(9):e70900.
                doi: 10.1002/fsn3.70900pubmed: 40927047google scholar: lookup
              6. Goh B, Soares Magalhães RJ, Ciocchetta S, Liu W, Sikulu-Lord MT. Identification of visible and near-infrared signature peaks for arboviruses and Plasmodium falciparum. PLoS One 2025;20(4):e0321362.
                doi: 10.1371/journal.pone.0321362pubmed: 40244986google scholar: lookup
              7. Schwarz ER, Long MT. Comparison of West Nile Virus Disease in Humans and Horses: Exploiting Similarities for Enhancing Syndromic Surveillance. Viruses 2023 May 24;15(6).
                doi: 10.3390/v15061230pubmed: 37376530google scholar: lookup
              Subscribe to our newsletter
              Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.